Equity Capital Markets

Taysha Gene Therapies

06/26
|
$230.0 Million
.
Piper Sandler served as bookrunner for Taysha Gene Therapies on its June 2026 CMFO
Sub-Type
CMFO
Sub-Sector
Biopharma